The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $140.59

Today's change-0.60 -0.42%
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $140.59

Today's change-0.60 -0.42%
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.

Amgen Inc down (U.S.)$0.60

Amgen Inc closed lower Thursday, dropping (U.S.)$0.60 or 0.42% to (U.S.)$140.59. Over the last five days, shares have lost 1.26% and are down 13.39% for the last year to date. This security has underperformed the S&P 500 by 20.62% during the last year.

Key company metrics

  • Open(U.S.) $140.83
  • Previous close(U.S.) $141.19
  • High(U.S.) $141.10
  • Low(U.S.) $138.83
  • Bid / Ask(U.S.) $138.50 / (U.S.) $140.89
  • YTD % change-13.39%
  • Volume4,387,570
  • Average volume (10-day)3,631,271
  • Average volume (1-month)5,052,916
  • Average volume (3-month)3,513,826
  • 52-week range(U.S.) $133.64 to (U.S.) $176.85
  • Beta1.15
  • Trailing P/E14.04×
  • P/E 1 year forward12.21×
  • Forward PEG1.62×
  • Indicated annual dividend(U.S.) $4.00
  • Dividend yield2.85%
  • Trailing EPS(U.S.) $10.01
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue5,8115,6885,5275,536
Total other revenue--------
Total revenue5,8115,6885,5275,536
Gross profit4,7844,6384,5094,465
Total cost of revenue1,0271,0501,0181,071
Total operating expense3,2843,3083,1253,503
Selling / general / administrative1,2441,2921,2031,416
Research & development9909008721,093
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)07827-84
Other operating expenses, total23-1257
Operating income2,5272,3802,4022,033
Interest income (expense), net non-operating-325-313-294-284
Gain (loss) on sale of assets--------
Other--------
Income before tax2,4182,2042,2581,913
Income after tax2,0171,8701,9001,800
Income tax, total401334358113
Net income2,0171,8701,9001,800
Total adjustments to net income--------
Net income before extra. items2,0171,8701,9001,800
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,0171,8701,9001,800
Inc. avail. to common incl. extra. items2,0171,8701,9001,800
Diluted net income2,0171,8701,9001,800
Dilution adjustment--------
Diluted weighted average shares753756760763
Diluted EPS excluding extraordinary itemsvalue per share2.682.472.502.36
Dividends per sharevalue per share1.001.001.000.79
Diluted normalized EPSvalue per share2.682.562.532.26